Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Topical pharmacotherapy for skin cancer
Giuseppe Micali, Francesco Lacarrubba, Maria Rita Nasca, et al.
Journal of the American Academy of Dermatology (2014) Vol. 70, Iss. 6, pp. 965.e1-965.e12
Closed Access | Times Cited: 77

Showing 26-50 of 77 citing articles:

Síndrome de Gorlin
I. Palacios‐Álvarez, Rogelio González‐Sarmiento, Emilia Fernández‐López
Actas Dermo-Sifiliográficas (2018) Vol. 109, Iss. 3, pp. 207-217
Open Access | Times Cited: 24
Development of bioadhesive polysaccharide-based films for topical release of the immunomodulatory agent imiquimod on oral mucosa lesions
Lucas Garcia Camargo, Paula de Freitas Rosa Remiro, Gabriela Souza Rezende, et al.
European Polymer Journal (2021) Vol. 151, pp. 110422-110422
Closed Access | Times Cited: 18
Enhanced Skin Permeation of 5-Fluorouracil through Drug-in-Adhesive Topical Patches
Sangseo Kim, Souha H. Youssef, Kyung Min Kirsten Lee, et al.
Pharmaceutics (2024) Vol. 16, Iss. 3, pp. 379-379
Open Access | Times Cited: 2
Laser-assisted drug delivery: Enhanced response to ingenol mebutate after ablative fractional laser treatment
Stephan Alexander Braun, Peter Hevezi, Bernhard Homey, et al.
Journal of the American Academy of Dermatology (2015) Vol. 72, Iss. 2, pp. 364-365
Closed Access | Times Cited: 19
Ingenol mebutate in actinic keratosis: a clinical, videodermoscopic and immunohistochemical study
Ivan Bobyr, Anna Campanati, Veronica Consales, et al.
Journal of the European Academy of Dermatology and Venereology (2016) Vol. 31, Iss. 2, pp. 260-266
Closed Access | Times Cited: 18
Immunomodulators for Non-Melanoma Skin Cancers: Updated Perspectives
Kristen Russomanno, Sara Abdel Azim, Vishal A. Patel
Clinical Cosmetic and Investigational Dermatology (2023) Vol. Volume 16, pp. 1025-1045
Open Access | Times Cited: 6
In vivo Confocal Laser Microscopy for monitoring of actinic keratosis treatment: a comparison with histopathologic assessment after treatment with topical 5% 5‐fluorouracil
Priscila Ishioka, Marcus Maia, Sarita Bartholomei Rodrigues, et al.
Journal of the European Academy of Dermatology and Venereology (2017) Vol. 32, Iss. 7, pp. 1155-1163
Closed Access | Times Cited: 17
Extramammary Paget disease of the vulva
Anastasia M. Konstantinova, Dmitry V. Kazakov
Seminars in Diagnostic Pathology (2020) Vol. 38, Iss. 1, pp. 62-70
Closed Access | Times Cited: 15
Regulation of bone regeneration with approved small molecule compounds
Erica J. Carbone, Komal Rajpura, Tao Jiang, et al.
Advances in Regenerative Biology (2014) Vol. 1, Iss. 1, pp. 25276-25276
Open Access | Times Cited: 15
Efficacy and Safety of Laser‐Assisted Combination Chemotherapy: An Explorative Imaging‐Guided Treatment With 5‐Fluorouracil and Cisplatin for Basal Cell Carcinoma
Emily Wenande, Kristoffer Hendel, Mette Mogensen, et al.
Lasers in Surgery and Medicine (2020) Vol. 53, Iss. 1, pp. 119-128
Closed Access | Times Cited: 14
Neoplastic Multifocal Skin Lesions: Biology, Etiology, and Targeted Therapies for Nonmelanoma Skin Cancers
Ana Rita Fernandes, Ana Cláudia Paiva‐Santos, Elena Sánchez‐López, et al.
Skin Pharmacology and Physiology (2017) Vol. 31, Iss. 2, pp. 59-73
Closed Access | Times Cited: 14
Rapidly-growing squamous cell carcinoma shortly after treatment with ingenol mebutate for actinic keratoses: report of two cases
Juan Antonio Moreno Romero, A. Campoy, Napoleón Paredes Pérez, et al.
British Journal of Dermatology (2015) Vol. 173, Iss. 6, pp. 1514-1517
Closed Access | Times Cited: 13
Management of keratinocyte carcinoma - Special considerations in the elderly
Alison Bailey, Brooke Vasicek, Joy Tao, et al.
International Journal of Women’s Dermatology (2019) Vol. 5, Iss. 4, pp. 235-245
Open Access | Times Cited: 12
Terapias no quirúrgicas para el carcinoma basocelular: revisión
Santiago Andrés Ariza, Sandra Beatriz Escobar Espinosa, María C. Naranjo
Actas Dermo-Sifiliográficas (2017) Vol. 108, Iss. 9, pp. 809-817
Closed Access | Times Cited: 12
Ingenol mebutate gel for the treatment of Bowen's disease: a case report of three patients
M. Salleras Redonnet, M. Codina‐Pascual
Dermatologic Therapy (2016) Vol. 29, Iss. 4, pp. 236-239
Open Access | Times Cited: 11
Bcl-2 knockdown by multifunctional lipid nanoparticle and its influence in apoptosis pathway regarding cutaneous melanoma: in vitro and ex vivo studies
Juliana Santos Rosa Viegas, Jackeline Souza Araujo, Marcel Nani Leite, et al.
Drug Delivery and Translational Research (2024) Vol. 15, Iss. 2, pp. 753-768
Closed Access | Times Cited: 1
Liposomal Avicequinone-B formulations: Aqueous solubility, physicochemical properties and apoptotic effects on cutaneous squamous cell carcinoma cells
Stephen Chu‐Sung Hu, Yung‐Shun Su, Yi-Chien Lai, et al.
Phytomedicine (2019) Vol. 58, pp. 152870-152870
Closed Access | Times Cited: 10
Resistance of Nonmelanoma Skin Cancer to Nonsurgical Treatments. Part I: Topical Treatments
Tamara Gracia‐Cazaña, Salvador González, Yolanda Gilaberte
Actas Dermo-Sifiliográficas (2016) Vol. 107, Iss. 9, pp. 730-739
Open Access | Times Cited: 9
Factors influencing response to ingenol mebutate therapy for actinic keratosis of face and scalp
Nevena Skroza, Ilaria Proietti, Nicoletta Bernardini, et al.
World Journal of Clinical Oncology (2017) Vol. 8, Iss. 5, pp. 405-411
Open Access | Times Cited: 8
Investigational drugs currently in phase II clinical trials for actinic keratosis
Flavia Lozzi, Caterina Lanna, Mauro Mazzeo, et al.
Expert Opinion on Investigational Drugs (2019) Vol. 28, Iss. 7, pp. 629-642
Closed Access | Times Cited: 8
LSD1: a viable therapeutic target in cutaneous squamous cell carcinoma?
Shaun Egolf, Brian C. Capell
Expert Opinion on Therapeutic Targets (2020) Vol. 24, Iss. 7, pp. 671-678
Open Access | Times Cited: 8
Nonsurgical Therapies for Basal Cell Carcinoma: A Review
Santiago Andrés Ariza, Sandra Beatriz Escobar Espinosa, María C. Naranjo
Actas Dermo-Sifiliográficas (2017) Vol. 108, Iss. 9, pp. 809-817
Open Access | Times Cited: 7
An overview of the medical management of nonmelanoma skin cancer
Lauren Metterle, Jeffrey S. Russell, Nishit Patel
Current Problems in Cancer (2015) Vol. 39, Iss. 4, pp. 226-236
Closed Access | Times Cited: 6
Queratosis actínicas: un modelo de campo de cancerización
Vicente García‐Patos
Piel (2014) Vol. 30, Iss. 6, pp. 352-357
Closed Access | Times Cited: 6
Erythroplasia of Queyrat treated with imiquimod 5% cream: The necessity of regimen guidelines
Maiko Yokoyama, Gyohei Egawa, Takamitsu Makino, et al.
Clinical Case Reports (2019) Vol. 7, Iss. 4, pp. 723-725
Open Access | Times Cited: 6

Scroll to top